anonymous
Guest
anonymous
Guest
Hi Lilly fiends
We have this new guy as CEO. So far so good but trying to understand his Lilly record. Was he demoted from VP commercial of the US immunology group? If so why? What was his real impact to baricitinib ? Good guy to run an up and coming biotech? CEO material? Please be fair and truthful
We have this new guy as CEO. So far so good but trying to understand his Lilly record. Was he demoted from VP commercial of the US immunology group? If so why? What was his real impact to baricitinib ? Good guy to run an up and coming biotech? CEO material? Please be fair and truthful